Re: Cabazitaxel versus Docetaxel as First-Line Therapy for Patients with Metastatic Castration-Resistant Prostate Cancer: A Randomized Phase III Trial-FIRSTANA.
作者信息
Taneja Samir S
出版信息
J Urol. 2018 Apr;199(4):893-894. doi: 10.1016/j.juro.2018.01.031. Epub 2018 Jan 18.
PMID:29642359
Abstract
摘要
Zotero 插件